Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor (Q46102928)
Jump to navigation
Jump to search
scientific article published on 2 March 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor |
scientific article published on 2 March 2009 |
Statements
1 reference
Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor (English)
1 reference
Pamela H Franklin
1 reference
Patricia N Banfor
1 reference
Paul Tapang
1 reference
Jason A Segreti
1 reference
Deborah L Widomski
1 reference
Kelly J Larson
1 reference
William T Noonan
1 reference
Gary A Gintant
1 reference
Steven K Davidsen
1 reference
Daniel H Albert
1 reference
Ryan M Fryer
1 reference
Bryan F Cox
1 reference
2 March 2009
1 reference
329
1 reference
3
1 reference
928-937
1 reference
Identifiers
1 reference